Australia is experience a groundbreaking medication for obesity: Retatrutide. This dual molecule – acting on both GLP-1 and GIP receptors – demonstrates promising results in global research, indicating meaningful drops in weight. While approval hasn't occurred with the Therapeutic Goods Administration (TGA), a number of Australians struggling b